FRAXIPARINE FRAXIPARINE FRAXIPARINE FRAXIPARINE

Dose: 250 mg
Single Dose: 250 (250)
Frequency: 12 hourly
Route: PO
Instructions:

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

. It is of Semi Synthetic origin and belongs to Sulphopyranosuronic acid. It belongs to Low Molecular Weight Heparin pharmacological group.The Molecular Weight of Nadroparin (Ca) is 3600.00.

Nadroparin (Ca) is contraindicated in conditions like Diabetic retinopathy,Severe uncontrolled hypertension,Hypersensitivity to any component of product.

The signs and symptoms that are produced after the acute overdosage of Nadroparin (Ca) include Hemorrhage.The symptomatic adverse reactions produced by Nadroparin (Ca) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Rashes, Allergic reactions, Thrombocytopenia, Bleeding, Pain at injection site, Hypoaldosteronism, Injection site hematoma.

Nadroparin (Ca) is primarily indicated in conditions like Prophylaxis of thrombosis, Pulmonary embolism, Thromboembolism, and can also be given in adjunctive therapy as an alternative drug of choice in Unstable angina.

No data regarding the interactions of Nadroparin (Ca) was found.

Elevation in ALT or AST

Drug should not be given to Paediatrics, patients suffering from Kidney dysfunction, and patients suffering from Liver Malfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Inj Store Between 15°C-30°C. Refrigeration and Freezing is not recommended.

Patients with recent or anticipated neuraxial anesthesia (epidural or spinal anesthesia) are at risk of spinal or epidural hematoma and subsequent paralysis. Patient should be closely monitored for sighns or symptoms of bleeding.Should be use with caution in patients with severe hepatic or renal disease. Safety and efficacy in pediatric patients have not been established. Should not be used interchangeably (unit for unit) with heparin or any other low molecular weight heparins.